23. CBD products which fulfill the definition of the CBPM will be Course B controlled drugs and subject to Regulation 16A as well as pertinent constraints for Schedule 2 medicines [footnote five]. CBD products that fulfill the definition of a cannabis-based medicine which has been individually scheduled is going to be Course B medicines in the righ